• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏骤停和心源性休克的体外生命支持

Extracorporeal Life Support for Cardiac Arrest and Cardiogenic Shock.

作者信息

Elliott Andrea, Dahyia Garima, Kalra Rajat, Alexy Tamas, Bartos Jason, Kosmopoulos Marinos, Yannopoulos Demetri

机构信息

Department of Medicine, Division of Cardiology, University of Minnesota Minneapolis, MN.

Department of Medicine, Division of Cardiology, Center for Resuscitation Medicine, University of Minnesota Minneapolis, MN.

出版信息

US Cardiol. 2021 Nov 10;15:e23. doi: 10.15420/usc.2021.13. eCollection 2021.

DOI:10.15420/usc.2021.13
PMID:39720488
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11664775/
Abstract

The rising incidence and recognition of cardiogenic shock has led to an increase in the use of veno-arterial extracorporeal membrane oxygenation (VA-ECMO). As clinical experience with this therapy has increased, there has also been a rapid growth in the body of observational and randomized data describing the clinical and logistical considerations required to institute a VA-ECMO program with successful clinical outcomes. The aim of this review is to summarize this contemporary data in the context of four key themes that pertain to VA-ECMO programs: the principles of patient selection; basic hemodynamic and technical principles underlying VA-ECMO; contraindications to VA-ECMO therapy; and common complications and intensive care considerations that are encountered in the setting of VA-ECMO therapy.

摘要

心源性休克发病率的上升及其诊断率的提高,导致静脉-动脉体外膜肺氧合(VA-ECMO)的使用增加。随着这种治疗临床经验的积累,描述建立具有成功临床结果的VA-ECMO项目所需的临床和后勤考虑因素的观察性和随机数据也迅速增加。本综述的目的是在与VA-ECMO项目相关的四个关键主题背景下总结这些当代数据:患者选择原则;VA-ECMO的基本血流动力学和技术原理;VA-ECMO治疗的禁忌症;以及VA-ECMO治疗过程中常见的并发症和重症监护注意事项。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/466b/11664775/6ffdec5177f5/usc-15-e23-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/466b/11664775/cc1b24b223d4/usc-15-e23-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/466b/11664775/6ffdec5177f5/usc-15-e23-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/466b/11664775/cc1b24b223d4/usc-15-e23-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/466b/11664775/6ffdec5177f5/usc-15-e23-g002.jpg

相似文献

1
Extracorporeal Life Support for Cardiac Arrest and Cardiogenic Shock.心脏骤停和心源性休克的体外生命支持
US Cardiol. 2021 Nov 10;15:e23. doi: 10.15420/usc.2021.13. eCollection 2021.
2
Scrutinizing the Role of Venoarterial Extracorporeal Membrane Oxygenation: Has Clinical Practice Outpaced the Evidence?审视静脉-动脉体外膜肺氧合的作用:临床实践是否超越了证据?
Circulation. 2024 Mar 26;149(13):1033-1052. doi: 10.1161/CIRCULATIONAHA.123.067087. Epub 2024 Mar 25.
3
Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) for emergency cardiac support.静脉-动脉体外膜肺氧合(VA-ECMO)用于紧急心脏支持。
J Crit Care. 2018 Apr;44:31-38. doi: 10.1016/j.jcrc.2017.10.011. Epub 2017 Oct 12.
4
Treatment time limit for successful weaning from veno-arterial extracorporeal membrane oxygenation in cardiogenic shock.心源性休克患者成功撤离静脉-动脉体外膜肺氧合的治疗时间限制
ESC Heart Fail. 2024 Dec;11(6):3767-3774. doi: 10.1002/ehf2.14931. Epub 2024 Jul 11.
5
Parameters associated with successful weaning of veno-arterial extracorporeal membrane oxygenation: a systematic review.与成功撤机 veno-arterial 体外膜肺氧合相关的参数:系统评价。
Crit Care. 2022 Dec 5;26(1):375. doi: 10.1186/s13054-022-04249-w.
6
Short-term and intermediate outcomes of cardiogenic shock and cardiac arrest patients supported by venoarterial extracorporeal membrane oxygenation.应用体外膜肺氧合支持的心源休克和心脏骤停患者的短期和中期结局。
J Cardiothorac Surg. 2021 Oct 9;16(1):290. doi: 10.1186/s13019-021-01674-w.
7
Extracorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock: Results of the ECMO-CS Randomized Clinical Trial.体外膜肺氧合治疗心源性休克:ECMO-CS随机临床试验结果
Circulation. 2023 Feb 7;147(6):454-464. doi: 10.1161/CIRCULATIONAHA.122.062949. Epub 2022 Nov 6.
8
Overview of Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) Support for the Management of Cardiogenic Shock.静脉-动脉体外膜肺氧合(VA-ECMO)支持治疗心源性休克概述
Front Cardiovasc Med. 2021 Jul 7;8:686558. doi: 10.3389/fcvm.2021.686558. eCollection 2021.
9
Left Ventricular Unloading During Extracorporeal Membrane Oxygenation in Patients With Cardiogenic Shock.体外膜肺氧合治疗心原性休克患者时的左心室卸载。
J Am Coll Cardiol. 2019 Feb 19;73(6):654-662. doi: 10.1016/j.jacc.2018.10.085.
10
Prevention and treatment of pulmonary congestion in patients undergoing venoarterial extracorporeal membrane oxygenation for cardiogenic shock.心源性休克患者接受静脉-动脉体外膜肺氧合时肺充血的预防与治疗
Eur Heart J. 2020 Oct 7;41(38):3753-3761. doi: 10.1093/eurheartj/ehaa547.

本文引用的文献

1
Concomitant Respiratory Failure Can Impair Myocardial Oxygenation in Patients with Acute Cardiogenic Shock Supported by VA-ECMO.VA-ECMO 支持下的急性心源性休克患者并发呼吸衰竭可导致心肌氧合受损。
J Cardiovasc Transl Res. 2022 Apr;15(2):217-226. doi: 10.1007/s12265-021-10110-2. Epub 2021 Feb 23.
2
Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association.心脏病与中风统计-2021 更新:美国心脏协会报告。
Circulation. 2021 Feb 23;143(8):e254-e743. doi: 10.1161/CIR.0000000000000950. Epub 2021 Jan 27.
3
The Minnesota mobile extracorporeal cardiopulmonary resuscitation consortium for treatment of out-of-hospital refractory ventricular fibrillation: Program description, performance, and outcomes.
明尼苏达移动体外心肺复苏联盟治疗院外难治性室颤:项目描述、实施情况及结果
EClinicalMedicine. 2020 Nov 13;29-30:100632. doi: 10.1016/j.eclinm.2020.100632. eCollection 2020 Dec.
4
Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial.针对院外心脏骤停和难治性心室颤动患者的高级再灌注策略(ARREST):一项 2 期、单中心、开放标签、随机对照试验。
Lancet. 2020 Dec 5;396(10265):1807-1816. doi: 10.1016/S0140-6736(20)32338-2. Epub 2020 Nov 13.
5
Veno-arterial extracorporeal membrane oxygenation (ECMO) in patients with cardiogenic shock: rationale and design of the randomised, multicentre, open-label EURO SHOCK trial.静脉-动脉体外膜肺氧合(ECMO)在心源性休克患者中的应用:随机、多中心、开放标签 EURO SHOCK 试验的原理和设计。
EuroIntervention. 2021 Feb 5;16(15):e1227-e1236. doi: 10.4244/EIJ-D-20-01076.
6
Part 3: Adult Basic and Advanced Life Support: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.第3部分:成人基础及高级生命支持:2020年美国心脏协会心肺复苏及心血管急救指南。
Circulation. 2020 Oct 20;142(16_suppl_2):S366-S468. doi: 10.1161/CIR.0000000000000916. Epub 2020 Oct 21.
7
Left Ventricular Unloading Is Associated With Lower Mortality in Patients With Cardiogenic Shock Treated With Venoarterial Extracorporeal Membrane Oxygenation: Results From an International, Multicenter Cohort Study.左心室卸载与使用体外膜肺氧合治疗的心源性休克患者的死亡率降低相关:一项国际多中心队列研究的结果。
Circulation. 2020 Dec;142(22):2095-2106. doi: 10.1161/CIRCULATIONAHA.120.048792. Epub 2020 Oct 9.
8
Extracorporeal cardiopulmonary resuscitation for acute aortic dissection during cardiac arrest: A nationwide retrospective observational study.心脏骤停期间急性主动脉夹层的体外心肺复苏:一项全国性回顾性观察研究。
Resuscitation. 2020 Nov;156:237-243. doi: 10.1016/j.resuscitation.2020.08.001. Epub 2020 Aug 12.
9
A novel veno-arteriovenous extracorporeal membrane oxygenation with double pump for the treatment of Harlequin syndrome.新型动静脉体外膜肺氧合双泵治疗 Harlequin 综合征。
Perfusion. 2020 May;35(1_suppl):65-72. doi: 10.1177/0267659120908409.
10
Patients treated with venoarterial extracorporeal membrane oxygenation have different baseline risk and outcomes dependent on indication and route of cannulation.接受静脉-动脉体外膜肺氧合治疗的患者,其基线风险和预后因适应症和插管途径而异。
Hellenic J Cardiol. 2021 Jan-Feb;62(1):38-45. doi: 10.1016/j.hjc.2020.04.013. Epub 2020 May 7.